Premium
NeuroSense Therapeutics Ltd (NRSN)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company’s lead product is PrimeC, an extended-release oral formulation of a fixe... NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company’s lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer’s, as well as under preclinical studies for the treatment of Parkinson’s disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer’s disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1099 | -12.7790697674 | 0.86 | 0.9 | 0.7501 | 117740 | 0.79803853 | CS |
| 4 | -0.1299 | -14.7613636364 | 0.88 | 0.93 | 0.7375 | 106232 | 0.81916183 | CS |
| 12 | -0.0879 | -10.4892601432 | 0.838 | 1.05 | 0.63 | 153416 | 0.79544628 | CS |
| 26 | -0.4599 | -38.0082644628 | 1.21 | 1.23 | 0.63 | 205746 | 0.86983638 | CS |
| 52 | -0.9499 | -55.8764705882 | 1.7 | 2.6 | 0.63 | 349488 | 1.26744869 | CS |
| 156 | -1.1299 | -60.1010638298 | 1.88 | 2.6 | 0.4 | 311918 | 1.16165626 | CS |
| 260 | -3.7999 | -83.5142857143 | 4.55 | 8.18 | 0.4 | 760299 | 3.12664558 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
